Risk factors associated with osteomyelitis due to Corynebacterium striatum in patients with diabetic foot

Med Clin (Barc). 2024 Jan 12;162(1):15-18. doi: 10.1016/j.medcli.2023.09.015. Epub 2023 Nov 18.
[Article in English, Spanish]

Abstract

Objective: Corynebacterium striatum (CS) is an emerging micro-organism in diabetic foot infection for which there are currently few studies. The objective was to analyze the risk factors (RF) related to CS osteomyelitis in patients with diabetic foot.

Methods: A case-control study was conducted in the Diabetic Foot Unit between 2015 and 2021. Forty-four patients with osteomyelitis due to CS (cases) and 44 patients with osteomyelitis due a different micro-organism (controls) were included.

Results: Peripheral artery disease (OR: 2.8, p = 0.037), atrial fibrillation (OR: 3.7, p = 0.034), ischemic diabetic foot (OR: 3.3, p = 0.020) and previous prolonged antibiotic therapy more than 14 days (OR: 3.4, p = 0.012) were identified as RF for osteomyelitis due to CS. When performing the multivariate analysis antibiotic therapy >14 days was independent RF (OR: 3.46; p = 0.017).

Conclusions: Previous antibiotic therapy received more than 14 days is an independent and statistically significant RF for CS osteomyelitis in patients with diabetic foot.

Keywords: Corynebacterium striatum; Diabetic foot; Osteomielitis; Osteomyelitis; Pie diabético.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Case-Control Studies
  • Corynebacterium
  • Diabetes Mellitus* / drug therapy
  • Diabetic Foot* / complications
  • Diabetic Foot* / therapy
  • Humans
  • Osteomyelitis* / etiology
  • Osteomyelitis* / microbiology
  • Risk Factors

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Corynebacterium striatum